Beginning July 1, 2026, the Medicare GLP-1 Bridge Program may allow eligible Medicare Part D patients to access certain obesity-indicated GLP-1 medications, including Foundayo, Wegovy, and certain Zepbound formulations, for no more than $50 per month through December 31, 2027
Generic semaglutide contains the same molecule and needs the same prescription
These include: Nausea Headaches Mild digestive upset Flushing Fatigue Its also worth noting that the long-term safety of taking an NAD+ supplement is still being studied, especially for high doses or prolonged periods of use
If you miss your scheduled injection day, take it as soon as you remember, then return to your regular schedule the following week
However, it makes you not hungry
References: 1 PMC62710672 Examine.com Research3 drbnaples.com4 opss.org5 cimahealth.com6 Examine.com7 sports-injury-physio.com8 PMC8504390